These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 8721156)

  • 1. Time course of striatal changes induced by 6-hydroxydopamine lesion of the nigrostriatal pathway, as studied by combined evaluation of rotational behaviour and striatal Fos expression.
    Labandeira-Garcia JL; Rozas G; Lopez-Martin E; Liste I; Guerra MJ
    Exp Brain Res; 1996 Feb; 108(1):69-84. PubMed ID: 8721156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Lopez-Martin E; Rozas G; Rodriguez J; Guerra MJ; Labandeira-Garcia JL
    Exp Brain Res; 1998 May; 120(2):153-63. PubMed ID: 9629957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic transplants normalize amphetamine- and apomorphine-induced Fos expression in the 6-hydroxydopamine-lesioned striatum.
    Cenci MA; Kalén P; Mandel RJ; Wictorin K; Björklund A
    Neuroscience; 1992; 46(4):943-57. PubMed ID: 1347413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
    Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
    Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transection of corticostriatal afferents reduces amphetamine- and apomorphine-induced striatal Fos expression and turning behaviour in unilaterally 6-hydroxydopamine-lesioned rats.
    Cenci MA; Björklund A
    Eur J Neurosci; 1993 Aug; 5(8):1062-70. PubMed ID: 8281310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between normal developing striatum and developing striatal grafts using drug-induced Fos expression and neuron-specific enolase immunohistochemistry.
    Labandeira-Garcia JL; Tobio JP; Guerra MJ
    Neuroscience; 1994 May; 60(2):399-415. PubMed ID: 7915411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fos expression in intrastriatal striatal grafts: regulation by host dopaminergic afferents.
    Mandel RJ; Wictorin K; Cenci MA; Björklund A
    Brain Res; 1992 Jun; 583(1-2):207-15. PubMed ID: 1504828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rotational behaviour and neurochemical changes in unilateral N-methyl-norsalsolinol and 6-hydroxydopamine lesioned rats.
    Moser A; Siebecker F; Nobbe F; Böhme V
    Exp Brain Res; 1996 Nov; 112(1):89-95. PubMed ID: 8951410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transection of corticostriatal afferents abolishes the hyperexpression of Fos and counteracts the development of rotational overcompensation induced by intrastriatal dopamine-rich grafts when challenged with amphetamine.
    Cenci MA; Björklund A
    Brain Res; 1994 Nov; 665(1):167-74. PubMed ID: 7882012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Turgeon SM; Fink JS
    Neuroscience; 1997 Jul; 79(1):79-93. PubMed ID: 9178866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1-dopamine receptor agonists selectively activate striatal c-fos independent of rotational behaviour.
    Robertson HA; Peterson MR; Murphy K; Robertson GS
    Brain Res; 1989 Dec; 503(2):346-9. PubMed ID: 2532558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Yates TM
    Neuroscience; 1999; 94(2):505-14. PubMed ID: 10579212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a role of endogenous opioids in the nigrostriatal system: influence of naloxone and morphine on nigrostriatal dopaminergic supersensitivity.
    Hirschhorn ID; Hittner D; Gardner EL; Cubells J; Makman MH
    Brain Res; 1983 Jun; 270(1):109-17. PubMed ID: 6409355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopaminergic grafts implanted into the neonatal or adult striatum: comparative effects on rotation and paw reaching deficits induced by subsequent unilateral nigrostriatal lesions in adulthood.
    Abrous DN; Torres EM; Dunnett SB
    Neuroscience; 1993 Jun; 54(3):657-68. PubMed ID: 8332254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-induced rotation intensity in unilateral dopamine-depleted rats is not correlated with end point or qualitative measures of forelimb or hindlimb motor performance.
    Metz GA; Whishaw IQ
    Neuroscience; 2002; 111(2):325-36. PubMed ID: 11983318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.
    Ueki A; Rosén L; Andbjer B; Finnman UB; Altamimi U; Janson AM; Goldstein M; Agnati LF; Fuxe K
    Exp Brain Res; 1993; 93(2):259-70. PubMed ID: 8098283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotype of striatal cells expressing c-Fos following amphetamine treatment of rats with intrastriatal dopaminergic grafts.
    Abrous DN; Bernard V; Le Moal M; Bloch B; Herman JP
    Eur J Neurosci; 1996 Dec; 8(12):2521-9. PubMed ID: 8996801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.